{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:30:04Z","timestamp":1784604604490,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1378\/chest.08-2990","type":"journal-article","created":{"date-parts":[[2009,5,2]],"date-time":"2009-05-02T00:15:10Z","timestamp":1241223310000},"page":"507-518","source":"Crossref","is-referenced-by-count":124,"title":["Churg-Strauss Syndrome in Patients Treated With Omalizumab"],"prefix":"10.1016","volume":"136","author":[{"given":"Michael E.","family":"Wechsler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lawrence-Miyasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-2990_bib1","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.08-2990_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1378\/chest.108.2.320","article-title":"Formes frustes of Churg-Strauss syndrome","volume":"108","author":"Churg","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.08-2990_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.279.6.455","article-title":"Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast","volume":"279","author":"Wechsler","year":"1998","journal-title":"JAMA"},{"key":"10.1378\/chest.08-2990_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2165\/00002018-199921040-00001","article-title":"Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?","volume":"21","author":"Wechsler","year":"1999","journal-title":"Drug Saf"},{"key":"10.1378\/chest.08-2990_bib5","unstructured":"Srinivasan R, Deane PM. Development of Churg-Strauss syndrome after initiation of omalizumab [abstract]. Paper presented at: Annual meeting of the American College of Allergy, Asthma and Immunology, Philadelphia, PA, 2006; 27"},{"key":"10.1378\/chest.08-2990_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMc061914","article-title":"Omalizumab for asthma","volume":"355","author":"Winchester","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-2990_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/02770900701767704","article-title":"Churg-Strauss vasculitis in a patient treated with omalizumab","volume":"45","author":"Bargagli","year":"2008","journal-title":"J Asthma"},{"key":"10.1378\/chest.08-2990_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000109296","article-title":"Omalizumab treatment associated with Churg-Strauss vasculitis","volume":"145","author":"Bargagli","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1378\/chest.08-2990_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejim.2007.09.001","article-title":"Churg-Strauss syndrome associated with omalizumab","volume":"19","author":"Pu\u00e9chal","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1378\/chest.08-2990_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaci.2007.10.040","article-title":"Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment","volume":"121","author":"Ruppert","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.08-2990_bib11","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.151.5.2623","article-title":"Humanization of an antibody directed against IgE","volume":"151","author":"Presta","year":"1993","journal-title":"J Immunol"},{"key":"10.1378\/chest.08-2990_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1164\/ajrccm.164.supplement_1.2103025","article-title":"Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders","volume":"164","author":"Schulman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-2990_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.08-2990_bib14","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1542\/peds.108.2.e36","article-title":"Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab)","volume":"108","author":"Milgrom","year":"2001","journal-title":"Pediatrics"},{"key":"10.1378\/chest.08-2990_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1183\/09031936.01.00092101","article-title":"The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics","volume":"18","author":"Sol\u00e8r","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.08-2990_bib16","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1542\/peds.110.5.e55","article-title":"Omalizumab improves asthma-related quality of life in children with allergic asthma [abstract]","volume":"110","author":"Lemanske","year":"2002","journal-title":"Pediatrics"},{"key":"10.1378\/chest.08-2990_bib17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2222.2004.1916.x","article-title":"Omalizumab 011 International Study Group: efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma","volume":"34","author":"Holgate","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1378\/chest.08-2990_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2004.00770.x","article-title":"The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma","volume":"60","author":"Bousquet","year":"2005","journal-title":"Allergy"},{"key":"10.1378\/chest.08-2990_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1378\/chest.08-2990_bib20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1398-9995.2008.01654.x","article-title":"Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma","volume":"63","author":"Humbert","year":"2008","journal-title":"Allergy"},{"key":"10.1378\/chest.08-2990_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.rmed.2008.06.002","article-title":"Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study","volume":"102","author":"Niven","year":"2008","journal-title":"Respir Med"},{"key":"10.1378\/chest.08-2990_bib22","first-page":"1076","article-title":"Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective","volume":"32","author":"Harrold","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1378\/chest.08-2990_bib23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1067\/mai.2002.120854","article-title":"Asthma therapies and Churg-Strauss syndrome","volume":"109","author":"Lilly","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.08-2990_bib25","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.24285","article-title":"The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome","volume":"60","author":"Zwerina","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1034\/j.1399-3003.2000.15e29.x","article-title":"Inhaled corticosteroids and Churg-Strauss syndrome: a report of five cases","volume":"15","author":"Le Gall","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.08-2990_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1378\/chest.117.3.708","article-title":"Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma","volume":"117","author":"Wechsler","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.08-2990_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/pds.1353","article-title":"Asthma drug use and the development of Churg-Strauss syndrome (CSS)","volume":"16","author":"Harrold","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1378\/chest.08-2990_bib30","first-page":"560","article-title":"Omalizumab and Churg-Strauss syndrome","volume":"63","author":"Stanciu","year":"2008","journal-title":"Allergy"},{"key":"10.1378\/chest.08-2990_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/blr.2005.24.344","article-title":"Final guidance: good pharmacovigilance practices and pharmacoepidemiologic assessment","volume":"24","author":"Food and Drug Administration","year":"2005","journal-title":"Biotech Law Report"},{"key":"10.1378\/chest.08-2990_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000103228","article-title":"Administration of anti-IgE to a Churg-Strauss syndrome patient","volume":"144","author":"Giavina-Bianchi","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1378\/chest.08-2990_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/thx.2006.076513","article-title":"Apparent response to anti-IgE therapy in two patients with refractory \u201cforme fruste\u201d of Churg-Strauss syndrome","volume":"63","author":"Pabst","year":"2008","journal-title":"Thorax"},{"key":"10.1378\/chest.08-2990_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/rccm.200312-1651OC","article-title":"Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma","volume":"170","author":"Djukanovi\u0107","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.08-2990_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0049-0172(95)80015-8","article-title":"Epidemiology of systemic vasculitis: changing incidence or definition?","volume":"25","author":"Watts","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","article-title":"Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom","volume":"43","author":"Watts","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-2990_bib38","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/ard.60.12.1156a","article-title":"Epidemiology of vasculitis in Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-2990_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.11115","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions","volume":"49","author":"Gonzalez-Gay","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib40","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/39.12.1396","article-title":"Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany","volume":"39","author":"Reinhold-Keller","year":"2000","journal-title":"Rheumatology"},{"key":"10.1378\/chest.08-2990_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/rheumatology\/41.5.540","article-title":"No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register","volume":"41","author":"Reinhold-Keller","year":"2002","journal-title":"Rheumatology"},{"key":"10.1378\/chest.08-2990_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","article-title":"Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register","volume":"53","author":"Reinhold-Keller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib43","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01450893","article-title":"Primary vasculitis in a Norwegian community hospital: a retrospective study","volume":"17","author":"Haugeberg","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1378\/chest.08-2990_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2004.022335","article-title":"Incidence of primary systemic vasculitides in Vilnius: a university hospital population-based study","volume":"64","author":"Dadoniene","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1378\/chest.08-2990_bib45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","article-title":"Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden","volume":"46","author":"Mohammad","year":"2007","journal-title":"Rheumatology"},{"key":"10.1378\/chest.08-2990_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulmatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-2990_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<179::AID-PDS414>3.0.CO;2-K","article-title":"Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription; event monitoring cohort studies","volume":"8","author":"Martin","year":"1999","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1378\/chest.08-2990_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1081-1206(10)62015-7","article-title":"Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients","volume":"88","author":"Loughlin","year":"2002","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236920960489X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001236920960489X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:19:04Z","timestamp":1684973944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001236920960489X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S001236920960489X"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-2990","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}